Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Hansa Biopharma Major Shareholding Notification 2019

May 27, 2019

3057_iss_2019-05-27_d80c57a3-f8da-4647-adf9-29c66e0a251e.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer Hansa Biopharma AB

Holder

Invesco Ltd.

Instrument

Instrument Ordinary SE0002148817
Before the transaction
Shares 0
Voting rights 0
Transaction
Reason for major shareholding notification Corporate action
Date 24/05/2019
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 2,705,663
Directly held voting rights 0
Indirectly held voting rights 2,705,663
Percentage
Directly held shares 6.64265 %
Directly held voting rights 0 %
Indirectly held voting rights 6.74785 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 6.74785 % 2,705,663
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 6.74785 % 2,705,663
Chain
of
controlling
companies
Voting rights % Voting rights Company
2,308,935 5.75842 Invesco Advisers, Inc.
396,728 0.98942 Invesco Capital Management LLC
Group
total
holdings
Voting rights 2,705,663
Percentage of voting rights 6.74785

Published

27/05/2019 11:09

Contact

Name Philippa Holmes
Phone 004401491417447 Email [email protected]

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25